Qty 2 - 0.5mm x 0.5cm Platinum VISICOILS With a 10mm spacer in 21g x 20cm Needle
Qty 2 - 0.5mm x 0.5cm Platinum VISICOILS With a 10mm spacer in 21g x 20cm Needle2 - 0.50mm x 0.5cm VISICOIL MR separated by a 10mm spacer (Non-Stranded) loaded in an 21 gauge pre-waxed brachytherapy needle.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.